Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: A Gynecologic Oncology Group Study

Cancer

Volumn 107, Issue 12, 2006, Pages 2786-2791

  Von Gruenigen, Vivian E ^a,b   Tian, Chunqiao ^c   Frasure, Heidi ^a,b   Waggoner, Steven ^a,b   Keys, Henry ^d,f   Barakat, Richard R ^e  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f University MacDonald Women's Hospital ^*  (United States)

Author keywords

Body mass index (BMI); Endometrial cancer; Obesity; Side effects; Survival

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; ETHNIC DIFFERENCE; FEMALE; GASTROINTESTINAL TOXICITY; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; BODY MASS INDEX; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; OBESITY, MORBID; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33845580407     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22351     Document Type: Article

References (27)

1. Jemal A, Murray T, Ward E, et al. Cancer Statistics 2005. CA Cancer J Clin. 2005;54:10-30.
2. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol. 1974;2:122-129.
3. Anderson BA, Connor JP, Andrews JI, et al. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol. 1996;174:1171-1179.
4. Kennedy AW, Austin JM, Look KY, Munger CB. The Society of Gynecologic Oncologists Outcomes Task Force. Study of endometrial cancer: initial experiences. Gynecol Oncol. 2000;79:379-398.
5. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage 1 and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55-65.
6. Hoskins WJ, Perez CA, Young RC. Principles and practice of gynecologic oncology, 4th edition. Philadelphia: Lippincott-Raven; 2005.
7. Everett E, Tamimi H, Greer B, et al. The effect of body mass index on clinical/pathologic features, surgical morbidity and outcome in patients with endometrial cancer. Gynecol Oncol. 2003;90:150-157.
8. von Gruenigen VE, Gil KM, Erasure HE, Grandon M, Hopkins MP, Jenison EL. Complementary medicine use, diet and exercise in endometrial cancer survivors. J Cancer Integ Med. 2005;3:13-18.
9. The National Heart, Lung, and Blood Institute Obesity Education Initiative. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Available: www.nhlbi.nih.gov/guidelines/ obesity/practgde.htm. Accessed July 7, 2004.
10. Prevalence of overweight and obesity among adults. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/3and4/overweight.htm. Accessed July 7, 2004.
11. Folsom AR, Kaye SA, Potter JD, Prineas RJ. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer Res. 1989;49:6828-6831.
12. Calle EE, Rodriquez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348: 1625-1638.
13. Loi S, Milne RL, Friedlander ML, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1686-1691.
14. Amling CL, Riffenburgh RH, Sun L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2004;22:439-445.
15. Enger SM, Greif JM, Polikoff J, Press M. Body weight correlates with mortality in early-stage breast cancer. Arch Surg. 2004;139:954-960.
16. Rodriquez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev. 2001;10:345-353.
17. Bentzen SM, Dische S. Morbidity related to axillary irradiation in the treatment of breast cancer. Acta Oncol. 2000;39:337-347.
18. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-751.
19. Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98:484-495.
20. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2002;11:822-828.
21. Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol. 2000;152:847-854.
22. Excess weight linked to 90,000 US cancer deaths annually. CA Cancer J Clin. 2003;53:203-204.
23. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment and survival. Am J Public Health. 2004;94:2104-2111.
24. Randall TC, Armstrong K. Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol. 2003;21:4200-4206.
25. Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival and mortality for malignancy tumors of the uterine corpus. Cancer. 2003;98:176-186.
26. Jereczek-Fossa BA, Badzio A, Jassem J. Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases. Radiother Oncol 2003;68:33-39.
27. Creutzberg CL, van Putten WLJ, Koper PC, et al. for the PORTEC Study Group. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial. Int J Radiation Oncology Biol Phys. 2001;51:1246-1255.